Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Integrating geospatial tools is crucial for enhancing control strategies against human lymphatic filarial infections in Ghana: A comprehensive review

Kwarteng EVS, Asiedu E, Amewu EKA, et al. Elsevier BV. Parasite Epidemiology and Control. 2025;
Download PDF
Publication

Evaluating the effectiveness of mass drug administration on lymphatic filariasis transmission and assessment of post-mass drug administration surveillance in Nigeria’s Federal Capital Territory

Amanyi-Enegela JA, Kumbur J, Okunade F, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2025; 14 (1) : 1-10.
Download PDF
Publication

Post-MDA assessment for filariasis in urban and rural areas of Balasore District, Odisha

Sai Chandan Das , Biswabara Rout , Akshya Kumar Sethi , et al. Indian Society of Malaria and Other Communicable Diseases. Journal of Communicable Diseases. 2025; 57 (2) : 95-101.
Download PDF
Publication

Reactive case detection can improve the efficiency of lymphatic filariasis surveillance compared to random sampling, Samoa 2023

Mayfield HJ, Sartorius B, McLure A, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2025;
Publication

Global insights can accelerate India’s journey towards the elimination of lymphatic filariasis as a public health problem

Jabir M, Rahi M. BMJ. BMJ Global Health. 2025; 10 (7) : 12.
Download PDF
Publication

The Feasibility of Using Telehealth for Training Health Care Workers and Persons with Disability on Integrated Rehabilitation and Prevention of Impairments and Disabilities of Leprosy, Lymphatic Filariasis, Diabetes, Pressure Ulcers, and Other Chronic Wou

Lardizabal-Dofitas B, Leochico CFD, Ortiz YRH, et al. University of the Philippines Manila. Acta Medica Philippina - The National Health Science Journal. 2025;
Download PDF
Publication

Impact of mass drug administration of ivermectin and albendazole on transmission of Wuchereria bancrofti lymphatic filariasis from 2001 to 2017 in Burkina Faso

Sawadogo A, Zoungrana J, Ouédraogo AG, et al. Wiley. Tropical Medicine & International Health. 2025; 30 (7) : 633-639.
Download PDF
Publication

Vector-borne helminthiases: a road map for current and future research to support control and elimination in sub-Saharan Africa

Kamgno J, Adeleke M, Basáñez M, et al. Elsevier BV. The Lancet Infectious Diseases. 2025;
Download PDF
Publication

Subcutaneous Postauricular Filariasis in an Adult Male: An Extremely Rare Presentation

Begam N, Bashar MA, Mungutwar V. Springer Science and Business Media LLC. Indian Journal of Otolaryngology and Head & Neck Surgery. 2025;
Download PDF
Publication

Healthcare Undergraduates’ Perception and Practice Regarding Lymphatic Filariasis and Mass Drug Administration in a Tertiary Care Facility in Eastern India

Biswas B, Pathak HN, Gupta P, et al. Springer Science and Business Media LLC. Cureus. 2025;

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Lymphatic filariasis (Elephantiasis)

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD